263 related articles for article (PubMed ID: 19961314)
1. Protection against focal ischemic injury to the brain by trans-sodium crocetinate. Laboratory investigation.
Manabe H; Okonkwo DO; Gainer JL; Clarke RH; Lee KS
J Neurosurg; 2010 Oct; 113(4):802-9. PubMed ID: 19961314
[TBL] [Abstract][Full Text] [Related]
2. Metabolic reflow as a therapy for ischemic brain injury.
Manabe H; Wang Y; Yoshimura R; Cai Y; Fitzgerald M; Clarke R; Lee KS
Acta Neurochir Suppl; 2011; 110(Pt 2):87-91. PubMed ID: 21125451
[TBL] [Abstract][Full Text] [Related]
3. Trans-sodium crocetinate improves outcomes in rodent models of occlusive and hemorrhagic stroke.
Wang Y; Yoshimura R; Manabe H; Schretter C; Clarke R; Cai Y; Fitzgerald M; Lee KS
Brain Res; 2014 Oct; 1583():245-54. PubMed ID: 25128603
[TBL] [Abstract][Full Text] [Related]
4. Trans-sodium crocetinate provides neuroprotection against cerebral ischemia and reperfusion in obese mice.
Deng J; Xiong L; Zuo Z
J Neurosci Res; 2015 Apr; 93(4):615-22. PubMed ID: 25491171
[TBL] [Abstract][Full Text] [Related]
5. Preischemic but not postischemic zinc protoporphyrin treatment reduces infarct size and edema accumulation after temporary focal cerebral ischemia in rats.
Kadoya C; Domino EF; Yang GY; Stern JD; Betz AL
Stroke; 1995 Jun; 26(6):1035-8. PubMed ID: 7762020
[TBL] [Abstract][Full Text] [Related]
6. Infarct tolerance against temporary focal ischemia following spreading depression in rat brain.
Yanamoto H; Hashimoto N; Nagata I; Kikuchi H
Brain Res; 1998 Feb; 784(1-2):239-49. PubMed ID: 9518633
[TBL] [Abstract][Full Text] [Related]
7. Mild hypothermia reduces infarct size resulting from temporary but not permanent focal ischemia in rats.
Ridenour TR; Warner DS; Todd MM; McAllister AC
Stroke; 1992 May; 23(5):733-8. PubMed ID: 1579972
[TBL] [Abstract][Full Text] [Related]
8. Trans-sodium crocetinate increases oxygen delivery to brain parenchyma in rats on oxygen supplementation.
Okonkwo DO; Wagner J; Melon DE; Alden T; Stone JR; Helm GA; Jane JA
Neurosci Lett; 2003 Dec; 352(2):97-100. PubMed ID: 14625032
[TBL] [Abstract][Full Text] [Related]
9. Zinc protoporphyrin, zinc ion, and protoporphyrin reduce focal cerebral ischemia.
Zhao YJ; Yang GY; Domino EF
Stroke; 1996 Dec; 27(12):2299-303. PubMed ID: 8969797
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety profile of the carotenoid trans sodium crocetinate administered to rabbits following multiple infarct ischemic strokes: a combination therapy study with tissue plasminogen activator.
Lapchak PA
Brain Res; 2010 Jan; 1309():136-45. PubMed ID: 19891959
[TBL] [Abstract][Full Text] [Related]
11. Effect of trans sodium crocetinate on brain tumor oxygenation. Laboratory investigation.
Sheehan J; Sherman J; Cifarelli C; Jagannathan J; Dassoulas K; Olson C; Rainey J; Han S
J Neurosurg; 2009 Aug; 111(2):226-9. PubMed ID: 19326986
[TBL] [Abstract][Full Text] [Related]
12. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
13. Treatment of focal cerebral ischemia with synthetic oligopeptide corresponding to lectin domain of selectin.
Morikawa E; Zhang SM; Seko Y; Toyoda T; Kirino T
Stroke; 1996 May; 27(5):951-5; discussion 956. PubMed ID: 8623118
[TBL] [Abstract][Full Text] [Related]
14. High-dose methylprednisolone treatment in experimental focal cerebral ischemia.
Slivka AP; Murphy EJ
Exp Neurol; 2001 Jan; 167(1):166-72. PubMed ID: 11161604
[TBL] [Abstract][Full Text] [Related]
15. Temporary and permanent focal cerebral ischemia in the mouse: assessment of cerebral blood flow, brain damage and blood-brain barrier permeability.
Mao Y; Yang G; Zhou L
Chin Med J (Engl); 2000 Apr; 113(4):361-6. PubMed ID: 11775237
[TBL] [Abstract][Full Text] [Related]
16. Reperfusion increases neutrophils and leukotriene B4 receptor binding in rat focal ischemia.
Barone FC; Schmidt DB; Hillegass LM; Price WJ; White RF; Feuerstein GZ; Clark RK; Lee EV; Griswold DE; Sarau HM
Stroke; 1992 Sep; 23(9):1337-47; discussion 1347-8. PubMed ID: 1381529
[TBL] [Abstract][Full Text] [Related]
17. Use of mild intraischemic hypothermia versus mannitol to reduce infarct size after temporary middle cerebral artery occlusion in rats.
Karibe H; Zarow GJ; Weinstein PR
J Neurosurg; 1995 Jul; 83(1):93-8. PubMed ID: 7782857
[TBL] [Abstract][Full Text] [Related]
18. The effect of ritanserin, a 5-HT2 receptor antagonist, on ischemic cerebral blood flow and infarct volume in rat middle cerebral artery occlusion.
Takagi K; Ginsberg MD; Globus MY; Busto R; Dietrich WD
Stroke; 1994 Feb; 25(2):481-5; discussion 485-6. PubMed ID: 8303760
[TBL] [Abstract][Full Text] [Related]
19. The effect of oxygen therapy on brain damage and cerebral pO(2) in transient focal cerebral ischemia in the rat.
Hou H; Grinberg O; Williams B; Grinberg S; Yu H; Alvarenga DL; Wallach H; Buckey J; Swartz HM
Physiol Meas; 2007 Aug; 28(8):963-76. PubMed ID: 17664686
[TBL] [Abstract][Full Text] [Related]
20. Interstitial pO2 in ischemic penumbra and core are differentially affected following transient focal cerebral ischemia in rats.
Liu S; Shi H; Liu W; Furuichi T; Timmins GS; Liu KJ
J Cereb Blood Flow Metab; 2004 Mar; 24(3):343-9. PubMed ID: 15091115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
